emphysema alpha alpha 1at deficiency conceptualized result insufficient alpha 1at allowing neutrophil elastase destroy lung parenchyma addition deficiency alpha 1at individuals resulting mutations alpha 1at gene recognized unknown reasons increased numbers neutrophils lungs compared normal individuals knowledge alveolar macrophages surface receptors neutrophil elastase hypothesized neutrophil accumulation lower respiratory tract alpha 1at deficiency result release neutrophil chemotactic activity alveolar macrophages bind uninhibited neutrophil elastase consistent hypothesis alpha alveolar macrophages spontaneously released nearly threefold neutrophil chemotactic activity normal alveolar macrophages analysis alpha macrophage supernates hplc molecular sieve chromatography radioimmunoassay absorption antibody revealed majority chemotactic activity leukotriene b4 ltb4 mediator absent normal macrophage supernates consistent hypothesis incubation normal macrophages human neutrophil elastase resulted release neutrophil chemotactic mediator furthermore purified human alpha 1at able prevent neutrophil elastase stimulating macrophages release chemotactic factor findings suggest absence normal antineutrophil elastase screen lower respiratory tract permits free neutrophil elastase bind alveolar macrophages resulting release ltb4 process attracts neutrophils alveoli alpha 1at deficient individuals accelerating lung destruction characterizes disorder NUMBER antitrypsin 1at deficient 1at deficient reverse phase anti ltb4